METIMEDI
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

METIMEDI Trademark

Serial Number: 88693805 • Registration: 6084402

METIMEDI is a trademark filed by MetiMedi pharmaceuticals Co., LTD. on November 15, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MetiMedi pharmaceuticals Co., LTD. (4 trademarks)

Suite 908 IBS tower
Incheon 22006 , KR

Entity Type: 03

Trademark Details

Filing Date

November 15, 2019

Registration Date

June 23, 2020

Published for Opposition

April 7, 2020

Goods & Services

Anti-cancer preparations; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for immunity adjustment; Vaccines; Pharmaceutical agents for regenerating cells; Anti-inflammatory preparations; Pharmaceutical agents affecting digestive organs; Cardiovascular pharmaceutical preparations; Chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Chemico-pharmaceutical preparations, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Pharmaceuticals for medical purposes for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Antibacterial substances for medical purposes; Antibodies for medical purposes for the treatment of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Chemical preparations for medical purpose, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Diagnostic kits for medical diagnostic purposes comprising reagents for use in disease testing, health monitoring and more generally, predictive and preventive medicine in the fields of detecting immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Diagnostic pharmaceutical preparations for medical purposes; Antibiotics; Tumor suppressing agents; Chemotherapeutics

Research and development of vaccines and medicines; Crude medicines research; Medical and scientific research on adult diseases; Medical and scientific research on cancer; Pharmaceutical products development; Research on the subject of pharmaceuticals; Pharmaceutical product evaluation; Consultancy pertaining to pharmacology; Research for medical products; Medical research; Chemistry services, namely, chemistry consultation, research in the field of chemistry, laboratory research and analysis in the field of chemistry; Chemical research and analysis; Research and development of medical products for others

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 23, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 17, 2022 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Mar 17, 2022 EWOR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 17, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 17, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 17, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Jun 23, 2020 R.PR
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Apr 15, 2020 ISPO
TEAS DELETE 1(B) BASIS RECEIVED
Apr 13, 2020 D1BR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2020 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 4, 2020 PREV
POST PUBLICATION AMENDMENT - ENTERED
Mar 4, 2020 CHPB
ASSIGNED TO LIE
Mar 2, 2020 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 25, 2020 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 25, 2020 CHAN
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 25, 2020 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 25, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 25, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 25, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 25, 2020 COAR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 24, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 24, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 24, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 24, 2020 CNEA
ASSIGNED TO EXAMINER
Feb 20, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 21, 2019 NWOS
NEW APPLICATION ENTERED
Nov 19, 2019 NWAP